Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2017

Sep 23, 2017

30561_dirs_2017-09-22_594e20a6-ebfd-4d33-9e6a-988169793ec6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-09-22

Reporting Person: PAPADOPOULOS STELIOS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-22 Common Stock S 10000 $25.40 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1034314 Direct

Footnotes

F1: Shares were held by Fondation Sante, of which the Reporting Person is co-trustee.

F2: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.